Modeling of pharmacodynamic (PD) biomarkers (BM) related to CDK4/6 inhibition and exploratory BM-response (progression free survival [PFS]) analyses in patients with advanced breast cancer. This is an ...
Much of the blood drawn for laboratory analysis is wasted. In a clinical setting where your blood is being taken multiple times a day, wouldn't it be better for the laboratory to use a smaller amount ...
Investigators have developed a new risk score that assesses a person's risk for developing ALS, as well as for survival after diagnosis, using a blood sample based on exposure to toxins in the ...
Please provide your email address to receive an email when new articles are posted on . Extra blood tubes were used for additional testing at a rate of 7%, according to findings published in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results